PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 55 filers reported holding PASSAGE BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $125 | -15.0% | 130,188 | +21.9% | 0.01% | -33.3% |
| Q4 2022 | $147 | -99.9% | 106,836 | +25.4% | 0.02% | +28.6% |
| Q3 2022 | $106,000 | -50.0% | 85,196 | -5.0% | 0.01% | -56.2% |
| Q2 2022 | $212,000 | +0.5% | 89,704 | +31.8% | 0.03% | +14.3% |
| Q1 2022 | $211,000 | +43.5% | 68,039 | +194.7% | 0.03% | +55.6% |
| Q4 2021 | $147,000 | -32.9% | 23,086 | +5.0% | 0.02% | -18.2% |
| Q3 2021 | $219,000 | – | 21,979 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $49,399,000 | 20.45% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,185,869 | $11,811,000 | 9.97% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $24,879,000 | 7.18% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $49,892,000 | 3.99% |
| Orbimed Advisors | 6,962,899 | $69,350,000 | 0.76% |
| Boxer Capital, LLC | 1,928,315 | $19,206,000 | 0.67% |
| Vivo Capital, LLC | 539,263 | $5,371,000 | 0.24% |
| Logos Global Management LP | 125,010 | $1,245,000 | 0.09% |
| Weiss Multi-Strategy Advisers LLC | 336,034 | $3,347,000 | 0.07% |
| Virtus ETF Advisers LLC | 14,687 | $146,000 | 0.06% |